1 Study Coverage
1.1 Gabapentin Enacarbil Product Introduction
1.2 Market by Type
1.2.1 Global Gabapentin Enacarbil Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Gabapentin Enacarbil Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Post-Herpetic Neuralgia (PHN)
1.3.3 Restless Legs Syndrome (RLS)
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gabapentin Enacarbil Sales Estimates and Forecasts 2017-2028
2.2 Global Gabapentin Enacarbil Revenue Estimates and Forecasts 2017-2028
2.3 Global Gabapentin Enacarbil Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Gabapentin Enacarbil Sales by Region
2.4.1 Global Gabapentin Enacarbil Sales by Region (2017-2022)
2.4.2 Global Sales Gabapentin Enacarbil by Region (2023-2028)
2.5 Global Gabapentin Enacarbil Revenue by Region
2.5.1 Global Gabapentin Enacarbil Revenue by Region (2017-2022)
2.5.2 Global Gabapentin Enacarbil Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gabapentin Enacarbil Sales by Manufacturers
3.1.1 Global Top Gabapentin Enacarbil Manufacturers by Sales (2017-2022)
3.1.2 Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gabapentin Enacarbil in 2021
3.2 Global Gabapentin Enacarbil Revenue by Manufacturers
3.2.1 Global Gabapentin Enacarbil Revenue by Manufacturers (2017-2022)
3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Enacarbil Revenue in 2021
3.3 Global Gabapentin Enacarbil Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gabapentin Enacarbil Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gabapentin Enacarbil Sales by Type
4.1.1 Global Gabapentin Enacarbil Historical Sales by Type (2017-2022)
4.1.2 Global Gabapentin Enacarbil Forecasted Sales by Type (2023-2028)
4.1.3 Global Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
4.2 Global Gabapentin Enacarbil Revenue by Type
4.2.1 Global Gabapentin Enacarbil Historical Revenue by Type (2017-2022)
4.2.2 Global Gabapentin Enacarbil Forecasted Revenue by Type (2023-2028)
4.2.3 Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
4.3 Global Gabapentin Enacarbil Price by Type
4.3.1 Global Gabapentin Enacarbil Price by Type (2017-2022)
4.3.2 Global Gabapentin Enacarbil Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Gabapentin Enacarbil Sales by Application
5.1.1 Global Gabapentin Enacarbil Historical Sales by Application (2017-2022)
5.1.2 Global Gabapentin Enacarbil Forecasted Sales by Application (2023-2028)
5.1.3 Global Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
5.2 Global Gabapentin Enacarbil Revenue by Application
5.2.1 Global Gabapentin Enacarbil Historical Revenue by Application (2017-2022)
5.2.2 Global Gabapentin Enacarbil Forecasted Revenue by Application (2023-2028)
5.2.3 Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
5.3 Global Gabapentin Enacarbil Price by Application
5.3.1 Global Gabapentin Enacarbil Price by Application (2017-2022)
5.3.2 Global Gabapentin Enacarbil Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gabapentin Enacarbil Market Size by Type
6.1.1 North America Gabapentin Enacarbil Sales by Type (2017-2028)
6.1.2 North America Gabapentin Enacarbil Revenue by Type (2017-2028)
6.2 North America Gabapentin Enacarbil Market Size by Application
6.2.1 North America Gabapentin Enacarbil Sales by Application (2017-2028)
6.2.2 North America Gabapentin Enacarbil Revenue by Application (2017-2028)
6.3 North America Gabapentin Enacarbil Market Size by Country
6.3.1 North America Gabapentin Enacarbil Sales by Country (2017-2028)
6.3.2 North America Gabapentin Enacarbil Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Gabapentin Enacarbil Market Size by Type
7.1.1 Europe Gabapentin Enacarbil Sales by Type (2017-2028)
7.1.2 Europe Gabapentin Enacarbil Revenue by Type (2017-2028)
7.2 Europe Gabapentin Enacarbil Market Size by Application
7.2.1 Europe Gabapentin Enacarbil Sales by Application (2017-2028)
7.2.2 Europe Gabapentin Enacarbil Revenue by Application (2017-2028)
7.3 Europe Gabapentin Enacarbil Market Size by Country
7.3.1 Europe Gabapentin Enacarbil Sales by Country (2017-2028)
7.3.2 Europe Gabapentin Enacarbil Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gabapentin Enacarbil Market Size by Type
8.1.1 Asia Pacific Gabapentin Enacarbil Sales by Type (2017-2028)
8.1.2 Asia Pacific Gabapentin Enacarbil Revenue by Type (2017-2028)
8.2 Asia Pacific Gabapentin Enacarbil Market Size by Application
8.2.1 Asia Pacific Gabapentin Enacarbil Sales by Application (2017-2028)
8.2.2 Asia Pacific Gabapentin Enacarbil Revenue by Application (2017-2028)
8.3 Asia Pacific Gabapentin Enacarbil Market Size by Region
8.3.1 Asia Pacific Gabapentin Enacarbil Sales by Region (2017-2028)
8.3.2 Asia Pacific Gabapentin Enacarbil Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Gabapentin Enacarbil Market Size by Type
9.1.1 Latin America Gabapentin Enacarbil Sales by Type (2017-2028)
9.1.2 Latin America Gabapentin Enacarbil Revenue by Type (2017-2028)
9.2 Latin America Gabapentin Enacarbil Market Size by Application
9.2.1 Latin America Gabapentin Enacarbil Sales by Application (2017-2028)
9.2.2 Latin America Gabapentin Enacarbil Revenue by Application (2017-2028)
9.3 Latin America Gabapentin Enacarbil Market Size by Country
9.3.1 Latin America Gabapentin Enacarbil Sales by Country (2017-2028)
9.3.2 Latin America Gabapentin Enacarbil Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gabapentin Enacarbil Market Size by Type
10.1.1 Middle East and Africa Gabapentin Enacarbil Sales by Type (2017-2028)
10.1.2 Middle East and Africa Gabapentin Enacarbil Revenue by Type (2017-2028)
10.2 Middle East and Africa Gabapentin Enacarbil Market Size by Application
10.2.1 Middle East and Africa Gabapentin Enacarbil Sales by Application (2017-2028)
10.2.2 Middle East and Africa Gabapentin Enacarbil Revenue by Application (2017-2028)
10.3 Middle East and Africa Gabapentin Enacarbil Market Size by Country
10.3.1 Middle East and Africa Gabapentin Enacarbil Sales by Country (2017-2028)
10.3.2 Middle East and Africa Gabapentin Enacarbil Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Arbor Pharma
11.1.1 Arbor Pharma Corporation Information
11.1.2 Arbor Pharma Overview
11.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Arbor Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Arbor Pharma Recent Developments
11.2 Astellas
11.2.1 Astellas Corporation Information
11.2.2 Astellas Overview
11.2.3 Astellas Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Astellas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Astellas Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Glenmark Pharma
11.4.1 Glenmark Pharma Corporation Information
11.4.2 Glenmark Pharma Overview
11.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Glenmark Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Glenmark Pharma Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Depomed
11.6.1 Depomed Corporation Information
11.6.2 Depomed Overview
11.6.3 Depomed Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Depomed Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Depomed Recent Developments
11.7 Teva
11.7.1 Teva Corporation Information
11.7.2 Teva Overview
11.7.3 Teva Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Teva Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teva Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Overview
11.8.3 Mylan Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis Recent Developments
11.10 Apotex
11.10.1 Apotex Corporation Information
11.10.2 Apotex Overview
11.10.3 Apotex Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Apotex Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Apotex Recent Developments
11.11 Sun Pharmaceutical
11.11.1 Sun Pharmaceutical Corporation Information
11.11.2 Sun Pharmaceutical Overview
11.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sun Pharmaceutical Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sun Pharmaceutical Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Corporation Information
11.12.2 Aurobindo Pharma Overview
11.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Aurobindo Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aurobindo Pharma Recent Developments
11.13 Intas
11.13.1 Intas Corporation Information
11.13.2 Intas Overview
11.13.3 Intas Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Intas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Intas Recent Developments
11.14 Amneal
11.14.1 Amneal Corporation Information
11.14.2 Amneal Overview
11.14.3 Amneal Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Amneal Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Amneal Recent Developments
11.15 Marksans Pharma
11.15.1 Marksans Pharma Corporation Information
11.15.2 Marksans Pharma Overview
11.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Marksans Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Marksans Pharma Recent Developments
11.16 Alkem
11.16.1 Alkem Corporation Information
11.16.2 Alkem Overview
11.16.3 Alkem Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Alkem Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alkem Recent Developments
11.17 Jiangsu Enhua
11.17.1 Jiangsu Enhua Corporation Information
11.17.2 Jiangsu Enhua Overview
11.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Jiangsu Enhua Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Jiangsu Enhua Recent Developments
11.18 Jiangsu Hengrui
11.18.1 Jiangsu Hengrui Corporation Information
11.18.2 Jiangsu Hengrui Overview
11.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Jiangsu Hengrui Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Jiangsu Hengrui Recent Developments
11.19 Sailike Pharma
11.19.1 Sailike Pharma Corporation Information
11.19.2 Sailike Pharma Overview
11.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Sailike Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Sailike Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gabapentin Enacarbil Industry Chain Analysis
12.2 Gabapentin Enacarbil Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gabapentin Enacarbil Production Mode & Process
12.4 Gabapentin Enacarbil Sales and Marketing
12.4.1 Gabapentin Enacarbil Sales Channels
12.4.2 Gabapentin Enacarbil Distributors
12.5 Gabapentin Enacarbil Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gabapentin Enacarbil Industry Trends
13.2 Gabapentin Enacarbil Market Drivers
13.3 Gabapentin Enacarbil Market Challenges
13.4 Gabapentin Enacarbil Market Restraints
14 Key Findings in The Global Gabapentin Enacarbil Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Gabapentin Enacarbil Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Global Gabapentin Enacarbil Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Gabapentin Enacarbil Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units)
Table 7. Global Gabapentin Enacarbil Sales Market Share by Region (2017-2022)
Table 8. Global Gabapentin Enacarbil Sales by Region (2023-2028) & (K Units)
Table 9. Global Gabapentin Enacarbil Sales Market Share by Region (2023-2028)
Table 10. Global Gabapentin Enacarbil Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Gabapentin Enacarbil Revenue Market Share by Region (2017-2022)
Table 12. Global Gabapentin Enacarbil Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Gabapentin Enacarbil Revenue Market Share by Region (2023-2028)
Table 14. Global Gabapentin Enacarbil Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Gabapentin Enacarbil Sales Share by Manufacturers (2017-2022)
Table 16. Global Gabapentin Enacarbil Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Gabapentin Enacarbil Revenue Share by Manufacturers (2017-2022)
Table 18. Gabapentin Enacarbil Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Gabapentin Enacarbil Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Gabapentin Enacarbil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2021)
Table 21. Gabapentin Enacarbil Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Gabapentin Enacarbil Product Offered
Table 23. Date of Manufacturers Enter into Gabapentin Enacarbil Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 26. Global Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 27. Global Gabapentin Enacarbil Sales Share by Type (2017-2022)
Table 28. Global Gabapentin Enacarbil Sales Share by Type (2023-2028)
Table 29. Global Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Gabapentin Enacarbil Revenue Share by Type (2017-2022)
Table 32. Global Gabapentin Enacarbil Revenue Share by Type (2023-2028)
Table 33. Gabapentin Enacarbil Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Gabapentin Enacarbil Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 36. Global Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 37. Global Gabapentin Enacarbil Sales Share by Application (2017-2022)
Table 38. Global Gabapentin Enacarbil Sales Share by Application (2023-2028)
Table 39. Global Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Gabapentin Enacarbil Revenue Share by Application (2017-2022)
Table 42. Global Gabapentin Enacarbil Revenue Share by Application (2023-2028)
Table 43. Gabapentin Enacarbil Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Gabapentin Enacarbil Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 46. North America Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 47. North America Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 50. North America Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 51. North America Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
Table 54. North America Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units)
Table 55. North America Gabapentin Enacarbil Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Gabapentin Enacarbil Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 58. Europe Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 59. Europe Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 62. Europe Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 63. Europe Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
Table 66. Europe Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units)
Table 67. Europe Gabapentin Enacarbil Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Gabapentin Enacarbil Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Gabapentin Enacarbil Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Gabapentin Enacarbil Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Gabapentin Enacarbil Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Gabapentin Enacarbil Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Gabapentin Enacarbil Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Gabapentin Enacarbil Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Gabapentin Enacarbil Revenue by Country (2023-2028) & (US$ Million)
Table 105. Arbor Pharma Corporation Information
Table 106. Arbor Pharma Description and Major Businesses
Table 107. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Arbor Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Arbor Pharma Recent Developments
Table 110. Astellas Corporation Information
Table 111. Astellas Description and Major Businesses
Table 112. Astellas Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Astellas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Astellas Recent Developments
Table 115. GlaxoSmithKline Corporation Information
Table 116. GlaxoSmithKline Description and Major Businesses
Table 117. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. GlaxoSmithKline Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GlaxoSmithKline Recent Developments
Table 120. Glenmark Pharma Corporation Information
Table 121. Glenmark Pharma Description and Major Businesses
Table 122. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Glenmark Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Glenmark Pharma Recent Developments
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Major Businesses
Table 127. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Pfizer Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Pfizer Recent Developments
Table 130. Depomed Corporation Information
Table 131. Depomed Description and Major Businesses
Table 132. Depomed Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Depomed Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Depomed Recent Developments
Table 135. Teva Corporation Information
Table 136. Teva Description and Major Businesses
Table 137. Teva Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Teva Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Teva Recent Developments
Table 140. Mylan Corporation Information
Table 141. Mylan Description and Major Businesses
Table 142. Mylan Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Mylan Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Mylan Recent Developments
Table 145. Novartis Corporation Information
Table 146. Novartis Description and Major Businesses
Table 147. Novartis Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Novartis Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Novartis Recent Developments
Table 150. Apotex Corporation Information
Table 151. Apotex Description and Major Businesses
Table 152. Apotex Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Apotex Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Apotex Recent Developments
Table 155. Sun Pharmaceutical Corporation Information
Table 156. Sun Pharmaceutical Description and Major Businesses
Table 157. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Sun Pharmaceutical Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Sun Pharmaceutical Recent Developments
Table 160. Aurobindo Pharma Corporation Information
Table 161. Aurobindo Pharma Description and Major Businesses
Table 162. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Aurobindo Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Aurobindo Pharma Recent Developments
Table 165. Intas Corporation Information
Table 166. Intas Description and Major Businesses
Table 167. Intas Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Intas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Intas Recent Developments
Table 170. Amneal Corporation Information
Table 171. Amneal Description and Major Businesses
Table 172. Amneal Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. Amneal Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Amneal Recent Developments
Table 175. Marksans Pharma Corporation Information
Table 176. Marksans Pharma Description and Major Businesses
Table 177. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 178. Marksans Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Marksans Pharma Recent Developments
Table 180. Alkem Corporation Information
Table 181. Alkem Description and Major Businesses
Table 182. Alkem Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 183. Alkem Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Alkem Recent Developments
Table 185. Jiangsu Enhua Corporation Information
Table 186. Jiangsu Enhua Description and Major Businesses
Table 187. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 188. Jiangsu Enhua Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Jiangsu Enhua Recent Developments
Table 190. Jiangsu Hengrui Corporation Information
Table 191. Jiangsu Hengrui Description and Major Businesses
Table 192. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 193. Jiangsu Hengrui Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Jiangsu Hengrui Recent Developments
Table 195. Sailike Pharma Corporation Information
Table 196. Sailike Pharma Description and Major Businesses
Table 197. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 198. Sailike Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Sailike Pharma Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Gabapentin Enacarbil Distributors List
Table 203. Gabapentin Enacarbil Customers List
Table 204. Gabapentin Enacarbil Market Trends
Table 205. Gabapentin Enacarbil Market Drivers
Table 206. Gabapentin Enacarbil Market Challenges
Table 207. Gabapentin Enacarbil Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Enacarbil Product Picture
Figure 3. Global Gabapentin Enacarbil Market Share by Type in 2021 & 2028
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Gabapentin Enacarbil Market Share by Application in 2021 & 2028
Figure 6. Post-Herpetic Neuralgia (PHN)
Figure 7. Restless Legs Syndrome (RLS)
Figure 8. Others
Figure 9. Gabapentin Enacarbil Report Years Considered
Figure 10. Global Gabapentin Enacarbil Sales 2017-2028 (K Units)
Figure 11. Global Gabapentin Enacarbil Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Gabapentin Enacarbil Revenue 2017-2028 (US$ Million)
Figure 13. Global Gabapentin Enacarbil Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Gabapentin Enacarbil Sales Market Share by Region (2017-2022)
Figure 15. Global Gabapentin Enacarbil Sales Market Share by Region (2023-2028)
Figure 16. North America Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units)
Figure 17. North America Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Gabapentin Enacarbil Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Gabapentin Enacarbil in the World: Market Share by Gabapentin Enacarbil Revenue in 2021
Figure 28. Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 30. Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
Figure 31. Global Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 32. Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
Figure 33. North America Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 34. North America Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
Figure 35. North America Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 36. North America Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
Figure 37. North America Gabapentin Enacarbil Sales Share by Country (2017-2028)
Figure 38. North America Gabapentin Enacarbil Revenue Share by Country (2017-2028)
Figure 39. United States Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 42. Europe Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
Figure 43. Europe Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 44. Europe Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
Figure 45. Europe Gabapentin Enacarbil Sales Share by Country (2017-2028)
Figure 46. Europe Gabapentin Enacarbil Revenue Share by Country (2017-2028)
Figure 47. Germany Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 48. France Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Gabapentin Enacarbil Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Gabapentin Enacarbil Revenue Share by Region (2017-2028)
Figure 58. China Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 61. India Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 68. Latin America Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 70. Latin America Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Gabapentin Enacarbil Sales Share by Country (2017-2028)
Figure 72. Latin America Gabapentin Enacarbil Revenue Share by Country (2017-2028)
Figure 73. Mexico Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Gabapentin Enacarbil Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Gabapentin Enacarbil Revenue Share by Country (2017-2028)
Figure 82. Turkey Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million)
Figure 85. Gabapentin Enacarbil Value Chain
Figure 86. Gabapentin Enacarbil Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
